<DOC>
	<DOCNO>NCT02568878</DOCNO>
	<brief_summary>- Assess antidepressant/anxiolytic effect creatine male female methamphetamine user - Assess creatine 's effect methamphetamine use - Assess safety creatine male methamphetamine user depression</brief_summary>
	<brief_title>Creatine Depressed Male Female Methamphetamine Users</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Current primary diagnosis methamphetamine dependence abuse , methamphetamine prefer drug abuse Current diagnosis major depressive disorder ( primary substanceinduced ) Current diagnosis anxiety disorder ( primary substanceinduced ) Current Hamilton Depression Rating scale score &gt; = 16 Current Hamilton Anxiety Scale score &gt; = 18 If take psychotropic medication depress anxious mood , regimen must stable &gt; = 4 week prior creatine treatment initiation Persons unable provide adequate inform consent Persons clinically significant suicidal homicidal risk Primary substancerelated diagnosis methamphetamine dependence abuse Positive pregnancy test ( female ) History renal disease Clinically significant medical neurological illness identify history , physical exam laboratory test History hypersensitivity reaction creatine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Depression</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Methamphetamine dependence</keyword>
</DOC>